Device Firms Struggling With Trial Monitoring Could Receive BIMO Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA's Division of Bioresearch Monitoring will convene a June meeting of industry stakeholders to commence development of a best practices guidance for medical device clinical trial monitoring